Navigation Links
Over 40 Hospitals Lend Support for Individual Insurance Market Reform
Date:12/3/2008

LANSING, Mich., Dec. 3 /PRNewswire/ -- Consumers for Fair and Affordable Insurance Reform (CFAIR) is pleased to announce four major hospital systems, including 41 hospitals, are supporting the need for individual insurance market reform.

In a letter to state legislators, Ken Matzick, President and Chief Executive Officer of Beaumont Hospitals, and several other hospital executives wrote, "The state's current regulatory structure for individual health insurance is in need of significant repair. We are concerned as the individual market continues to grow, Blue Cross and Blue Shield, as the insurer of last resort, will not be able to affordably price health care coverage and will not be able to financially sustain the mounting losses in this market sector, jeopardizing the future of healthcare coverage for thousands of Michigan residents who have nowhere else to turn for coverage. It is critical that market reform also provide vital consumer protections for your constituents and our patients and also help ensure the future viability of healthcare finance in Michigan."

"We've seen the effects of erroneous government assumptions in dealing with sectors of our economy -- all you have to do is look at our banking sector," CFAIR Executive Director John Truscott said. "We have a chance in Michigan to avoid a significant crisis in the future by making some very simple changes to regulations that are 30-years-old. The time to act is now."

The following hospitals have sent letters in support of individual market reform: Beaumont Hospitals, Charlevoix Area Hospitals, Chelsea Community Hospital, Chippewa County War Memorial Hospital, Dickinson County Healthcare System, Marquette General Health Systems, Metro Health Hospital, Michigan Health Ministries of Ascension Health, Portage Health, Trinity Health System, and the University of Michigan Health System.

Consumers for Fair and Affordable
'/>"/>

SOURCE Consumers for Fair and Affordable Insurance Reform
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Global Med Technologies(R) European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals
2. Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
3. New Research Estimates 1500 Lives Could Be Saved Annually if the Lowest Performing Hospitals for Coronary Artery Bypass Graft Surgery Performed as Well as Top-ranking Hospitals
4. Health Care Transparency Report Ranks Hospitals and Nursing Facilities on Efficiency and Productivity - Charity Care and Profits Increase
5. Zero MRSA or Patient Infections Reported After Two Years as D.I.S.C. Sports and Spine Center Sets New Standard for Specialty Hospitals
6. Hospitals to Lose an Average $10,000 to $20,000 per Case on Common Cardiovascular Procedures Under Medicares Value-based Purchasing Program
7. Southern New Jersey Hospitals Thriving, but Cautious in Light of Market Conditions
8. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
9. Nations Hospitals Thrive as N.J. Facilities Struggle
10. Abington Memorial One of Just Six Hospitals in the U.S. to Win Magnet Prize
11. Global Med Technologies(R), Inc.s Inlog Subsidiary Places Transfusion Management Software in Five Hospitals of the Civil Hospices of Lyon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...of local dance students will dance to raise money ...OLIS, Jan. 8 , , , WHO: ...l show off their talent in the 3rd annual Dance, ... Dance Arts Centre. The, event wi...r., Participants raise money thr...
(Date:1/8/2009)...ounced Acquisition in 2009 Continues Growth Trend ...-FirstCall/ -- IPC The Hospitalist Company, Inc. (...hysician group practice company, announced today t...dwest Acute Care Consultants, Inc. (MACC) in St. L...ed expansion in the St. Louis market, where IPC ha...
(Date:1/8/2009)...N, Jan. 8 The Pew Chari...s been named director, chemical and food safety pr...program. Olson, who was formerly deputy staff dire...n Environment and Public Works, brings nearly 25 y...sumer advocacy to Pew. , , "We are excited to ...
(Date:1/8/2009)...a., Jan. 8 Cephalon, In...aldino, Jr., Ph.D., Chairman and CEO will present...eld on January 13, 2009 in San Francisco, CA at ap... Time). The presentation will be webcast live on t...site. , , The webcast will be archived for one...
Breaking Medicine News(10 mins):Health News:Dance With Courage to Benefit Camp Courage 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...ns, polio is a disease from the past, a successful...oks.// But around the globe it’s a different story...s arguably the greatest-ever act in the name of th...f coordinated effort by millions of healthcare wor...
...the Johns Hopkins Bloomberg School of Public Healt...w test for detecting //the malaria parasite in hum...t for determining treatment, the method could pote...demiological studies where large-scale malaria scr...
...stino SJ, a Jesuit priest, well-known for his care...way on Monday at the age of 80. He was the MD, fou...ome, a centre for abandoned HIV-positive children....f People for Peace in Africa, paid the following t...
...dical workforce should be a key component of healt...the Victorian state//election, according to the Au...rkforce problems do not end with the opening of ne...’ said AMSA President, Teresa Cosgriff. ‘These stu...
Other Medicine News:Health News:Global Polio Eradication: A Campaign to Vaccinate Every Child on the Planet 2Health News:Safer Method for Large-Scale Malaria Screening Developed 2Health News:Prioritise Doctor Training in Election Health Promises: AMSA 2
(Date:1/8/2009)... treated at the initial dose in an ongoing Phase I... decline after three days , , Conference Call T...wswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. ... first cohort of an ongoing Phase Ib clinical tria...leoside polymerase inhibitor. ANA598 was very wel...
(Date:1/7/2009)...K, Md., Jan. 7 ImQuest Life Scienc... IND application to the Food and Drug Administrati...d pyrimidinedione HIV inhibitor IQP-0410. ImQuest ...e first quarter of 2009. IQP-0410 is a novel small... a nonnucleoside reverse transcriptase inhibitor (...
(Date:1/6/2009)...Expands on Successful Results from prior U.S., U.K...swire/ -- Vital Therapies, Inc. (VTI), a developme...nounced patient enrollment has begun for a randomi...ial that will study the Extracorporeal Liver Assis...cute Liver Failure (ALF) under three protocols. Th...
(Date:1/6/2009)...E, Md., Jan. 6 Sequella... focused on diseases of epidemic potential, announ...the treatment of tuberculosis (TB), was the first ...inical program contract to Dynport Vaccine Company...arded by the National Institute of Allergy and Inf...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Aspreva receives final court approval for acquisition by Galenica 8509 1Aspreva receives final court approval for acquisition by Galenica 8509 2Aspreva receives final court approval for acquisition by Galenica 8509 3Aspreva receives final court approval for acquisition by Galenica 8509 4Alsius Corporation Announces Program for Early Exercise of Warrants 8507 1Alsius Corporation Announces Program for Early Exercise of Warrants 8507 2Alsius Corporation Announces Program for Early Exercise of Warrants 8507 3Alsius Corporation Announces Program for Early Exercise of Warrants 8507 4New neuroimaging study identifies brain signature for cigarette cravings 8506 1New neuroimaging study identifies brain signature for cigarette cravings 8506 2Cumberland Pharmaceuticals Announces Appointments 8504 1Cumberland Pharmaceuticals Announces Appointments 8504 2
...SCO confirm safety findings,and demonstrate clinic...ectal and other types of cancer., PRINCETON, N.J.,...cals announced positive safety and efficacy result...Floxuridine), Liposome,Injection in patients with ...s were presented yesterday in a poster presentatio...
...(CSE: GEN) announced,today pre-clinical data illus...umab) antibody may have broad potential,to treat c...idermal,growth factor receptor). , Recently, mutat...f EGFr have been identified in tumors from lung ca...ctor in the potential success of,EGFr-directed tre...
Other Medicine Technology:Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 2Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 3
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: